Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs Oxytocin for Postpartum Hemorrhage Prevention
NCT02503319Phase 3Withdrawn
- Sponsor
- Azienda USL 1 di Massa e Carrara
- Start
- Jan 2016
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of tranexamic acid in postpartum hemorrhage (PPH) (3 arms), sponsored by Azienda USL 1 di Massa e Carrara. Primary endpoint: assessment of total blood loss. Planned start Jan 2016; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02503319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503319.